FINWIRES · TerminalLIVE
FINWIRES

BP透過與Cocuina-Manakin達成協議,擴大在委內瑞拉的天然氣業務。

By

-- 英國石油公司(BP)週三與委內瑞拉簽署了一份諒解備忘錄,共同開發位於特立尼達和多巴哥附近的科庫伊納-馬納金(Cocuina-Manakin)天然氣田。 該公司在回覆的問詢時表示,該協議在加拉加斯與委內瑞拉政府簽署,確定了雙方在海上天然氣資源開發和未來勘探方面的潛在合作領域。 該公司稱,該諒解備忘錄是在本週BP高級代表團訪問委內瑞拉期間簽署的,該代表團由BP執行副總裁威廉·林(William Lin)率領。 根據媒體報道,根據該協議,這家能源公司將主導開發位於特立尼達和多巴哥邊境附近的科庫伊納-馬納金氣田,同時評估洛蘭(Loran)海上區塊的其他勘探前景。 據報道,該合作還包括在洛蘭地區進行聯合勘探和天然氣商業化工作,包括殼牌(SHEL)在內的其他全球企業對該地區的興趣持續增長。 根據多家媒體報道,委內瑞拉加快了吸引外國業者的步伐,與埃尼集團(Eni)和雷普索爾公司(Repsol)等企業簽署了新的協議,以擴大上游產能。 該諒解備忘錄規定了在天然氣開發和未來勘探項目方面的合作,委內瑞拉國家石油公司(Petroleos de Venezuela)也包含在內。 據報道,林表示,該公司正在透過在加拉加斯設立常駐辦事處來加強其在委內瑞拉的業務。 該協議是在加拉加斯舉行的大型能源會議之後簽署的,該會議吸引了全球投資者,各公司正在推進長期計劃,包括預計將於2031年左右啟動的天然氣出口項目。 報道還稱,英國石油公司(BP)計劃將該氣田超過1兆立方英尺的天然氣輸送到特立尼達,加工成液化天然氣出口,從而加強區域供應鏈。

Price: $47.23, Change: $+0.43, Percent Change: +0.92%

Related Articles

Sectors

Sector Update: Financial

Financial stocks were higher late Thursday afternoon, with the NYSE Financial Index rising 1.3% and the State Street Financial Select Sector SPDR ETF (XLF) up 0.5%.The Philadelphia Housing Index climbed 1.6%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) added 1.5%.Bitcoin (BTC-USD) rose 0.9% to $76,409, and the yield for 10-year US Treasuries decreased 2.8 basis points to 4.39%.In corporate news, AvalonBay Communities (AVB) and Equity Residential (EQR) have held discussions over a potential merger, which would be one of the biggest real estate deals ever, Bloomberg reported. AvalonBay shares were down 1.1%, and Equity Residential was fractionally lower.

$AVB$EQR
Australia

Market Chatter: Zuckerberg, Cook Not Exploring Seattle Seahawks Bid

Meta Platforms (META) CEO Mark Zuckerberg and Apple (AAPL) CEO Tim Cook are not pursuing a bid for the National Football League's Seattle Seahawks, Bloomberg reported on Thursday, citing company and industry sources.A Meta spokesperson said Zuckerberg is not making any investment or bid for the team, while a person familiar with Cook's plans denied his involvement, the report said.Meta and Apple did not immediately respond to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $616.43, Change: $-52.69, Percent Change: -7.87%

$AAPL$META
Australia

Axsome Therapeutics Says FDA Approves Auvelity for Alzheimer's Disease Agitation

Axsome Therapeutics (AXSM) said Thursday the US Food and Drug Administration approved Auvelity for the treatment of agitation associated with Alzheimer's disease dementia.The approval was supported by two phase 3 clinical trials that showed the drug significantly improved agitation symptoms and resulted in a longer time to relapse compared with placebo.The medication acts on N-methyl-D-aspartate and sigma-1 receptors in the brain and is also approved for adults with major depressive disorder, the company added.Shares of Axsome were up more than 12% in Thursday trading.Price: $206.45, Change: $+22.50, Percent Change: +12.23%

$AXSM